The Pharmaceutical Pulse: A Year-End Reflection on Innovation, Politics, and Public Trust in 2025

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

A New Hope for Kidney Disease Patients? FDA Greenlights Voyxact, But Pricing Questions Linger

The Evolving Pharmaceutical Frontier: Navigating 2025's Landmark Shifts and Enduring Challenges

The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

The Pharmaceutical Whirlwind: From Weight Loss Wonders to Mind-Altering Medicines, A New Era Unfolds

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines